Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023.
- Second-quarter revenue came in at $1.18 billion, up 1% from Q2 2022; a 3% increase on a constant currency basis
- Net loss per share was $1.48 in Q2, compared to a loss per share of $3.40 in the year-ago quarter
- On an adjusted basis, it was earnings of $0.32 per share for Q2 2023, compared to $0.57 per share last year
- The company expects fiscal year 2023 consolidated revenue growth of approximately 1%
- It is looking for a loss in the range of $2.08 per share to $1.93 per share for fiscal 2023
- Full-year adjusted earnings per share is expected to be in the range of $0.75 to $0.90
Most Popular
LW Earnings: Key quarterly highlights from Lamb Weston’s Q3 2025 financial results
Lamb Weston Holdings, Inc. (NYSE: LW) reported its third quarter 2025 earnings results today. Net sales increased 4% to $1.52 billion compared to the same period a year ago. Net
CAG Earnings: Highlights of Conagra Brands’ Q3 2025 report
Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported a decrease in net sales and adjusted earnings for the third quarter of 2025. Net sales were
Fastenal Company (FAST) looks poised for a mixed start to FY25
Fastenal Company (NASDAQ: FAST) will report its first-quarter results on April 11, at 6:50 am ET. The company has been investing heavily to expand its digital footprint lately, and it
